Prostate Cancer
Showing NaN - NaN of 137
Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)
Not yet recruiting
- Prostate Cancer
- Docetaxel
- +2 more
-
Chicago, IllinoisNorthwestern University
Sep 27, 2023
Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)
Recruiting
- Prostate Cancer
- Docetaxel 75 mg/m2
- +2 more
-
Gilbert, Arizona
- +52 more
Feb 2, 2023
Prostate Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Cabazitaxel)
Active, not recruiting
- Prostate Cancer
- Nivolumab
- +3 more
-
Tucson, Arizona
- +59 more
Dec 22, 2022
Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)
Recruiting
- Small Cell Lung Cancer
- +8 more
- ladiratuzumab vedotin
- pembrolizumab
-
Chandler, Arizona
- +65 more
Dec 19, 2022
Prostate Cancer Trial in United States (TAK-700, Bicalutamide)
Active, not recruiting
- Prostate Cancer
-
Birmingham, Alabama
- +559 more
Dec 5, 2022
Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)
Recruiting
- Metastatic Prostate Cancer
- +3 more
-
San Diego, California
- +11 more
Nov 28, 2022
Prostate Cancer Trial in Worldwide (MRI-guided Transurethral Ultrasound Ablation)
Recruiting
- Prostate Cancer
- MRI-guided Transurethral Ultrasound Ablation
-
Los Angeles, California
- +14 more
Sep 12, 2022
Biomarkers in Subjects With Untreated Solid Tumors
Completed
- Breast Cancer
- +12 more
- Blood Sample Collection
-
Phoenix, Arizona
- +118 more
Aug 31, 2022
Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)
Prostate Cancer Trial in Worldwide (Standard of Care)
Recruiting
- Prostate Cancer
- Standard of Care
-
Birmingham, Alabama
- +107 more
Aug 17, 2022
Prostate Cancer Trial in Worldwide (Apalutamide, Placebo, Androgen Deprivation Therapy (ADT))
PSA, Prostate Cancer Trial in Chicago (Completing surveys)
Active, not recruiting
- PSA
- Prostate Cancer
- Completing surveys
-
Chicago, IllinoisMile Square Health Center
Jul 14, 2022
Prostate Cancer Trial in Chicago (Genomic Prostate Score assay and Multi-parametric magnetic resonance imaging study of the
Not yet recruiting
- Prostate Cancer
- Genomic Prostate Score assay and Multi-parametric magnetic resonance imaging study of the prostate
-
Chicago, IllinoisNorthwestern University
Jun 17, 2022
Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )
Prostate Cancer Trial in Washington, Chicago, Baltimore (Enzalutamide, LY2157299)
Recruiting
- Prostate Cancer
-
Washington, District of Columbia
- +3 more
Jun 1, 2022
Prostate Cancer Trial in Canada, United States (Radiation Therapy, Enzalutamide, Bicalutamide)
Recruiting
- Prostate Cancer
- Radiation Therapy
- +3 more
-
Gilbert, Arizona
- +107 more
Mar 17, 2022
Prostate Cancer, Hot Flashes Trial in Chicago (.5% Bupivacaine)
Terminated
- Prostate Cancer
- Hot Flashes
- .5% Bupivacaine
-
Chicago, IllinoisNorthwestern Memorial Hospital
Mar 3, 2022